Sperm factor oscillogenin
CA 2402722 A1 · Owner: Fissore, Rafael A. · Inventors: Fissore, Rafael A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The specification describes a novel compound oscillogenin, which is an active , agent in furthering oocyte fertilization by sperm or in parthenogenetic activation of an oocyte. The specification discloses methods of isolating oscillogenin to modulate fertility and to enhance parthenogenetic activation of oocytes for nuclear transfer or in ICSI procedures and methods of using , oscillogenin to test amounts of it in sperm and thus sperm fertility.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 21, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 21, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 21, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.